Dasiglucagon: A New Hope for Diazoxide-unresponsive, Nonfocal Congenital Hyperinsulinism?
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgad741 ↗Kurz gefasst
Editorial in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Gianluca Tamaro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Maternal and Child Health IRCCS "Burlo Garofolo," 34137 Trieste, Italy. Hauptthemen laut MEDLINE: Diazoxide, Congenital Hyperinsulinism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Maternal and Child Health IRCCS "Burlo Garofolo," 34137 Trieste, Italy.
- Department of Medicine, Surgery and Health Sciences, University of Trieste, 34129 Trieste, Italy.
ORCID-Profile: Gianluca Tamaro, Sara Solidoro, Gianluca Tornese
Zitieren
APA
Tamaro, G., Solidoro, S., & Tornese, G. (2024). Dasiglucagon: A New Hope for Diazoxide-unresponsive, Nonfocal Congenital Hyperinsulinism?. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad741
Vancouver
Tamaro G, Solidoro S, Tornese G. Dasiglucagon: A New Hope for Diazoxide-unresponsive, Nonfocal Congenital Hyperinsulinism?. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad741
BibTeX
@article{Tamaro2024,
author = {Tamaro, Gianluca and Solidoro, Sara and Tornese, Gianluca},
title = {Dasiglucagon: A New Hope for Diazoxide-unresponsive, Nonfocal Congenital Hyperinsulinism?},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgad741}
}
EUVIMED